Pharmaceuticals Inc (SCPH) reports a 24% revenue increase and strategic advancements, despite facing significant net losses ...

Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients ...

His on-court performance reflected his stat sheet stuffing, as Flagg had his prints all over every facet of the basketball ..

The Tennessee Titans will face the Minnesota Vikings in Week 11. Here’s the latest fantasy football news and advice to help you with your lineups this week and moving forward, especially regarding WR ...

Presented full dataset from first-in-human Phase 1a clinical trial demonstrating PMN310 was generally well-tolerated with monthly dosing and that ...

Q4 2024 Earnings Conference Call November 14, 2024 8:30 AM ETCompany ParticipantsJack Ezzell - CFOAustin Singleton ...

Revenues plunged 22% to £1.08bn with sales down 24% in mainland China as consumers in the world’s second largest economy reined in spending, especially in the second quarter which say a 27% slump.

Obtained agreement from FDA to initiate a Phase 1 trial evaluating multiple doses of Rhenium (186Re) Obisbemeda for the treatment of patients with leptomeningeal metastases (LM) Presented positive ReS ...

In the medical field, being fast, efficient, and correct can be the difference between life and death. This game-changing tool is helping cancer researchers and doctors save lives.

TriSalus Life Sciences, Inc. ( NASDAQ: TLSI) Q3 2024 Earnings Conference Call November 14, 2024 9:00 AM ET Jim Young - Senior Vice President, Investor Relations & Treasurer Mary Szela - President & ...

Presented full dataset from first-in-human Phase 1a clinical trial demonstrating PMN310 was generally well-tolerated with monthly dosing and that PMN310 demonstrated CSF levels indicative of potential ...

Barksdale Resources Corp. (TSXV: BRO) (OTCQX: BRKCF) ("Barksdale" or the "Company") is pleased to announce that it has ...